$MED 8-K SEC Filings

Filed On	Filing
26 Oct 2026	8-K: Results of Operations and Financial Condition BALTIMORE – (BUSINESS WIRE) — Medifast (NYSE: MED), the metabolic health and wellness company known for its science-backed comprehensive metabolic health system, Trilivy™, today reported results for the third quarter ended September 30, ...
03 Aug 2026	8-K: Results of Operations and Financial Condition
17 Jul 2026	8-K: Regulation FD Disclosure
01 Jun 2026	8-K: Departure/Election of Directors or Officers; Compensation
26 May 2026	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders +1 more
04 May 2026	8-K: Results of Operations and Financial Condition
20 Mar 2026	8-K: Entry into a Material Definitive Agreement; Departure/Election of Directors or Officers; Compensation +1 more
17 Feb 2026	8-K: Results of Operations and Financial Condition
05 Jan 2026	8-K: Departure/Election of Directors or Officers; Compensation
03 Nov 2025	8-K: Results of Operations and Financial Condition
04 Aug 2025	8-K: Results of Operations and Financial Condition
20 Jun 2025	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
28 Apr 2025	8-K: Results of Operations and Financial Condition
18 Feb 2025	8-K: Results of Operations and Financial Condition
04 Nov 2024	8-K: Termination of a Material Definitive Agreement; Results of Operations and Financial Condition
05 Aug 2024	8-K: Results of Operations and Financial Condition
21 Jun 2024	8-K: Departure/Election of Directors or Officers; Compensation; Submission of Matters to a Vote of Security Holders
29 Apr 2024	8-K: Results of Operations and Financial Condition
20 Feb 2024	8-K: Results of Operations and Financial Condition
13 Dec 2023	8-K: Other Events

Comments